Optic Company
Optic, an AI Drug Discovery company, is based in San Francisco. Our proprietary ligand-based and target-driven molecular search engine Bioptic.io identifies compounds by their activity-expressing fingerprints. It offers a novel approach to finding diverse candidate sets. In addition, we now also have an agentic AI platform for scientific and business due diligence on drug assets. Our pipeline includes multiple pre-clinical stage programs, showcasing our commitment to practical, AI-driven solutions in cancer therapy.
Funding Status:
Private
Employee Number:
11-50
Last Funding Date:
2025-04-10
Headquarters:
San Francisco,California,United States,North America
Founded Date:
2022-03-01
Total Funding:
12000000
Industry:
Quantum Chemistry
Super Industry:
Quantum Science Applications
Funding Stage:
Seed
Funding Total Value:
12000000
Last Funding Total Usd:
1000000
Last Funding Total Currency:
USD
Last Funding Total Value:
1000000
Founders:
Andrey Doronichev,Roman Doronin,Vlad Vinogradov